Back
Cincinnati Financial Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
58
CINF
Cincinnati Financial
Last Price:
117.94
Seasonality Move:
1.97%
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
41.55
Seasonality Move:
12.29%
Buy
58
Cincinnati Financial (CINF)
is a Buy
Is Cincinnati Financial a Buy, Sell or Hold?
- The current Cincinnati Financial [CINF] share price is $120.06. The Score for CINF is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- CINF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $41.87. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CINF Stock Price Chart
What is Cincinnati Financial's stock price today?
-
The Cincinnati Financial share price today is $120.06
The current trend is moderately bearish and CINF is experiencing buying pressure, which is a positive indicator for future bullish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $41.87
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
CINF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.18 | Buy |
| Relative Strength Index (14 RSI): | 56.92 | Buy |
| Chaikin Money Flow: | 419243 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (115.38 - 119.72) | Buy |
| Bollinger Bands (100): | (109.19 - 119.63) | Buy |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.15 | Sell |
| Relative Strength Index (14 RSI): | 42.44 | Sell |
| Chaikin Money Flow: | -669128 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.54 - 43.9) | Sell |
| Bollinger Bands (100): | (43.18 - 49.36) | Sell |
CINF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 118.38 | Buy |
| 20-day SMA: | 117.61 | Buy |
| 50-day SMA: | 118.75 | Buy |
| 200-day SMA: | 108.89 | Buy |
| 8-day EMA: | 118.4 | Buy |
| 20-day EMA: | 118.01 | Buy |
| 50-day EMA: | 117.24 | Buy |
| 200-day EMA: | 111.31 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.4 | Buy |
| 20-day SMA: | 42.66 | Sell |
| 50-day SMA: | 45.26 | Sell |
| 200-day SMA: | 42.06 | Sell |
| 8-day EMA: | 41.78 | Buy |
| 20-day EMA: | 42.68 | Sell |
| 50-day EMA: | 44.41 | Sell |
| 200-day EMA: | 44.22 | Sell |
Cincinnati Financial Earnings Growth & CINF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.16 per share, an increase this year of $0.74 per share, and an increase next year of $0.66 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.46 per share, an increase next quarter of $0.08 per share, an increase this year of $0.87 per share, and an increase next year of $1.24 per share.
Cincinnati Financial Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||